122 related articles for article (PubMed ID: 9234309)
1. 'Oncocheck': an international external quality assessment scheme for immunoassays of tumor markers.
Cohen R; Zucchelli GC; Fraysse M; Pilo A; Rigault MY; Grillet S; Bizollon CA
Nucl Med Biol; 1994 Apr; 21(3):483-93. PubMed ID: 9234309
[TBL] [Abstract][Full Text] [Related]
2. Analytical performance of CA 19.9, CA 125 and CA 15.3 assays as observed through an external quality assessment program.
Zucchelli GC; Pilo A; Chiesa MR; Masini S; Clerico A
Int J Biol Markers; 1994; 9(1):43-7. PubMed ID: 8051434
[TBL] [Abstract][Full Text] [Related]
3. Performance of immunoassays for ca 19-9, ca 15-3 and ca 125 tumour markers evaluated from an international quality assessment survey.
Pilo A; Zucchelli GC; Cohen R; Chiesa MR; Bizollon CA
Eur J Clin Chem Clin Biochem; 1996 Feb; 34(2):145-50. PubMed ID: 8833648
[TBL] [Abstract][Full Text] [Related]
4. Progress in immunoassays for serum prolactin: evidence from the UK External Quality Assessment Scheme (EQAS) 1980-1989.
Hanning I; Seth J; Bacon RR; Hunter WM; al-Sadie R
Ann Clin Biochem; 1991 Jan; 28 ( Pt 1)():91-7. PubMed ID: 2024943
[TBL] [Abstract][Full Text] [Related]
5. Immunoassay of CEA, CA 19-9, CA 125, and CA 15-3 on the automated systems ES 300 and ES 600: methodological evaluation from a multicentre collaborative study.
Zucchelli GC; Pilo A; Jaworek D; Masini S; Chiesa MR
Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):875-9. PubMed ID: 1489864
[TBL] [Abstract][Full Text] [Related]
6. [Progress in standardization of total PSA immunoassays].
Ishibashi M
Rinsho Byori; 2004 Jul; 52(7):618-24. PubMed ID: 15344562
[TBL] [Abstract][Full Text] [Related]
7. Comparison of immunoassays for tumor markers CA 19-9, CA 15-3 and CA 125: data from an international quality assessment scheme.
Pilo A; Zucchelli GC; Cohen R; Bizollon CA; Cappelli G; Cianetti A; Gion M; Piffanelli A; Bombardieri E
Tumori; 1995; 81(2):117-24. PubMed ID: 7539965
[TBL] [Abstract][Full Text] [Related]
8. Immunoassay external quality assessment schemes in France.
Cohen R; Bizollon CA
Ann Ist Super Sanita; 1991; 27(3):503-10. PubMed ID: 1809072
[TBL] [Abstract][Full Text] [Related]
9. External quality assessment of immunoassays of peptide hormones and tumour markers: principles and practice.
Seth J; Sturgeon CM; al-Sadie R; Hanning I; Ellis AR
Ann Ist Super Sanita; 1991; 27(3):443-52. PubMed ID: 1809063
[TBL] [Abstract][Full Text] [Related]
10. The CNR external quality assessment program for immunoassays: statistical analysis and reports for participants.
Pilo A; Zucchelli GC; Chiesa MR; Masini S; Clerico A
Ann Ist Super Sanita; 1991; 27(3):469-77. PubMed ID: 1809067
[TBL] [Abstract][Full Text] [Related]
11. External quality assessment of assays for hormones and tumor markers in Italian laboratories.
Zucchelli GC; Pilo A; Malvano R; Signorini C; Bolelli GF; Albertini A
Ann Ist Super Sanita; 1991; 27(3):479-86. PubMed ID: 1809068
[TBL] [Abstract][Full Text] [Related]
12. Italian external quality assessment scheme in immunoassay.
Pizzocolo G; Albertini A; Malvano R; Signorini C; Zucchelli G
Ann Ist Super Sanita; 1995; 31(1):123-9. PubMed ID: 8546360
[TBL] [Abstract][Full Text] [Related]
13. Status of External Quality Assessment on Tumor Markers in China.
Xiao Y; Zhang C; Zhao H; Wang W; He F; Zhong K; Yuan S; Wang Z
Clin Lab; 2015; 61(10):1383-90. PubMed ID: 26642698
[TBL] [Abstract][Full Text] [Related]
14. A long way to go for the harmonization of four immunoassays for carcinoembryonic antigen.
Zhang K; Huo H; Lin G; Yue Y; Wang Q; Li J
Clin Chim Acta; 2016 Feb; 454():15-9. PubMed ID: 26721316
[TBL] [Abstract][Full Text] [Related]
15. Determination of prostate-specific antigen in serum by immunoradiometric assay.
Lindstedt G; Jacobsson A; Lundberg PA; Hedelin H; Pettersson S; Unsgaard B
Clin Chem; 1990 Jan; 36(1):53-8. PubMed ID: 1688745
[TBL] [Abstract][Full Text] [Related]
16. Quality assessment of tumor marker determinations: a proposal for a supraregional scheme.
Piffanelli A; Giganti M; Colamussi P; Cittanti C; Pelizzola D; Barozzi R
Int J Biol Markers; 1994; 9(1):48-52. PubMed ID: 8051435
[TBL] [Abstract][Full Text] [Related]
17. External quality assessment of tumour marker analysis: state of the art and consequences for estimating diagnostic sensitivity and specificity.
Reinauer H; Wood WG
Ger Med Sci; 2005 May; 3():Doc02. PubMed ID: 19675719
[TBL] [Abstract][Full Text] [Related]
18. External quality control survey for alpha-fetoprotein assay.
Zucchelli GC; Pilo A; Ferdeghini M; Chiesa MR; Masini A; Clerico A
J Nucl Med Allied Sci; 1989; 33(3 Suppl):30-3. PubMed ID: 2480418
[TBL] [Abstract][Full Text] [Related]
19. Comparison of LUMIPULSE(®) G1200 With Kryptor and Modular E170 for the Measurement of Seven Tumor Markers.
Marlet J; Bernard M
J Clin Lab Anal; 2016 Jan; 30(1):5-12. PubMed ID: 25283278
[TBL] [Abstract][Full Text] [Related]
20. Standardization of tumor markers - priorities identified through external quality assessment.
Sturgeon C
Scand J Clin Lab Invest Suppl; 2016; 245():S94-9. PubMed ID: 27542005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
